AUTH/3753/3/23 Complainant v Novavax

Alleged promotion of Nuvaxovid to the public

  • Received
    10 March 2023
  • Case number
  • Applicable Code year
  • Completed
    30 May 2024
  • No breach Clause(s)
  • Additional sanctions
  • Appeal
    No appeal

Case Summary

This case was in relation to an advertisement for a COVID-19 vaccine, Nuvaxovid, published on the P3 Pharmacy website. The complainant alleged that this advertisement was presented to them without them having to confirm that they were a health professional.

The outcome under the 2021 Code was:


No Breach of Clause 5.1

Requirement to maintain high standards at all times

No Breach of Clause 26.1

Requirement not to advertise prescription only medicines to the public

This summary is not intended to be read in isolation.
For full details, please see the full case report below.